Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation

NCT04804267 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Idiopathic Constipation

Interventions

DRUG: Linaclotide
DRUG: LINZESS®
DRUG: Placebo

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.